Global Cancer Vaccine Markets to 2026: Approvals for Additional Indications, Competition, Increased Funding, Manufacturers' Strategies, Challenges in Cancer Vaccines Dublin, Aug. 13, 2021 (GLOBE NEWSWIRE) -- The "Cancer Vaccines: Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for cancer...

Global Human Papillomavirus Vaccine Market Estimated to Generate a Revenue of $9,283.6 Million By 2027, Growing at a CAGR of 12.0% from 2020-2027 – Informative Report [238 Pages] by Research Dive New York, USA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global human papillomavirus vaccine market is expected to generate a revenue of $9,283.6...

Global Human Papillomavirus Vaccine Market Projected to Reach up to $9,283.6 Million and Rise at a CAGR of 12.0% from 2020 to 2027 – Exclusive Report [238 Pages] by Research Dive New York, USA, Feb. 10, 2021 (GLOBE NEWSWIRE) -- According to a newly published report by Research Dive, the global human papillomavirus vaccine market is estimated to generate $9,283.6 million by...

Human Papillomavirus Vaccine Market to Reach USD 12.69 Billion by 2027: Increasing Need to Reduce HPV Infections to Add Momentum, says Fortune Business Insights™ Pune, Aug. 05, 2020 (GLOBE NEWSWIRE) -- The global Human Papillomavirus Vaccine market size will rise remarkably in the coming years on account of the rising prevalence of HPV associated cancer,...

Human Papillomavirus Vaccine Market to reach US$ 3.5 Bn by 2025; Most Promising Indication to Invest in is Cervical Cancer Albany, NY, March 20, 2018 (GLOBE NEWSWIRE) -- The global human papillomavirus vaccine market was valued at approximately US$ 2.0 Bn in 2016 is anticipated to register compound annual growth rate...